Literature DB >> 9574701

Comparison of nine commercially available enzyme-linked immunosorbent assays for detection of Giardia lamblia in fecal specimens.

W E Aldeen1, K Carroll, A Robison, M Morrison, D Hale.   

Abstract

Overall performance, including ease of use, total hands-on time, incubation and processing times, sensitivity, and specificity, of each of nine enzyme-linked immunosorbent assays (ELISAs) were compared by using 222 individual fecal samples submitted for the detection of Giardia lamblia. The assays evaluated were manufactured by Alexon, Inc., Cambridge Biotech Corp., Meridian, Inc., and Trend Scientific, Inc. All assays used polyclonal antibodies except the "new and improved" Microplate (direct and diluted methods) by Alexon, which is a monoclonal antibody assay. Seventy specimens were positive for G. lamblia by ELISA, ova and parasite test, and/or direct fluorescent-antibody assay. One hundred fifty two were negative by all three methods. Sensitivities and specificities ranged from 88.6 to 100% and 99.3 to 100%, respectively. The total hands-on time needed to run one specimen ranged from 1 min to 2 min 17 s per specimen. All except one commercially available ELISA were found to be rapid, sensitive, and specific for the detection of G. lamblia in fecal specimens.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9574701      PMCID: PMC104824          DOI: 10.1128/JCM.36.5.1338-1340.1998

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  10 in total

1.  Use of Hemo-De to eliminate toxic agents used for concentration and trichrome staining of intestinal parasites.

Authors:  W E Aldeen; D Hale
Journal:  J Clin Microbiol       Date:  1992-07       Impact factor: 5.948

2.  Numbers of Giardia in the feces of infected children.

Authors:  M Danciger; M Lopez
Journal:  Am J Trop Med Hyg       Date:  1975-03       Impact factor: 2.345

3.  Stool diagnosis of giardiasis using a commercially available enzyme immunoassay to detect Giardia-specific antigen 65 (GSA 65).

Authors:  J D Rosoff; C A Sanders; S S Sonnad; P R De Lay; W K Hadley; F F Vincenzi; D M Yajko; P D O'Hanley
Journal:  J Clin Microbiol       Date:  1989-09       Impact factor: 5.948

4.  Evaluation of nine immunoassay kits (enzyme immunoassay and direct fluorescence) for detection of Giardia lamblia and Cryptosporidium parvum in human fecal specimens.

Authors:  L S Garcia; R Y Shimizu
Journal:  J Clin Microbiol       Date:  1997-06       Impact factor: 5.948

5.  Evaluation of an enzyme-linked immunosorbent assay for the detection of Giardia lamblia in stool specimens.

Authors:  J E Rosenblatt; L M Sloan; S K Schneider
Journal:  Diagn Microbiol Infect Dis       Date:  1993 May-Jun       Impact factor: 2.803

6.  Enzyme immunoassay for detection of Giardia lamblia cyst antigens in formalin-fixed and unfixed human stool.

Authors:  H H Stibbs; M Samadpour; J F Manning
Journal:  J Clin Microbiol       Date:  1988-09       Impact factor: 5.948

Review 7.  Giardiasis.

Authors:  M S Wolfe
Journal:  Clin Microbiol Rev       Date:  1992-01       Impact factor: 26.132

8.  Evaluation of a commercially available enzyme-linked immunosorbent assay for Giardia lamblia antigen in stool.

Authors:  D G Addiss; H M Mathews; J M Stewart; S P Wahlquist; R M Williams; R J Finton; H C Spencer; D D Juranek
Journal:  J Clin Microbiol       Date:  1991-06       Impact factor: 5.948

9.  Evaluation of a commercially available ELISA assay for detection of Giardia lamblia in fecal specimens.

Authors:  W E Aldeen; D Hale; A J Robison; K Carroll
Journal:  Diagn Microbiol Infect Dis       Date:  1995-02       Impact factor: 2.803

10.  Sensitivity of microscopy versus enzyme immunoassay in the laboratory diagnosis of giardiasis.

Authors:  T G Mank; J O Zaat; A M Deelder; J T van Eijk; A M Polderman
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-08       Impact factor: 5.103

  10 in total
  14 in total

1.  Use of an enzyme immunoassay does not eliminate the need to analyze multiple stool specimens for sensitive detection of Giardia lamblia.

Authors:  K L Hanson; C P Cartwright
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

2.  Performance of three enzyme immunoassays and two direct fluorescence assays for detection of Giardia lamblia in stool specimens preserved in ECOFIX.

Authors:  D P Fedorko; E C Williams; N A Nelson; L B Calhoun; S S Yan
Journal:  J Clin Microbiol       Date:  2000-07       Impact factor: 5.948

3.  Detection of Giardia lamblia antigens in human fecal specimens by a solid-phase qualitative immunochromatographic assay.

Authors:  Lynne S Garcia; John Paul Garcia
Journal:  J Clin Microbiol       Date:  2006-10-25       Impact factor: 5.948

4.  Evaluation of ImmunoCard STAT test and ELISA versus light microscopy in diagnosis of giardiasis and cryptosporidiosis.

Authors:  H A Sadaka; M R Gaafar; R F Mady; N N Hezema
Journal:  Parasitol Res       Date:  2015-05-01       Impact factor: 2.289

5.  Evaluation of the Triage Micro Parasite Panel for detection of Giardia lamblia, Entamoeba histolytica/Entamoeba dispar, and Cryptosporidium parvum in patient stool specimens.

Authors:  S E Sharp; C A Suarez; Y Duran; R J Poppiti
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

Review 6.  Drug targets and mechanisms of resistance in the anaerobic protozoa.

Authors:  P Upcroft; J A Upcroft
Journal:  Clin Microbiol Rev       Date:  2001-01       Impact factor: 26.132

Review 7.  Treatment of giardiasis.

Authors:  T B Gardner; D R Hill
Journal:  Clin Microbiol Rev       Date:  2001-01       Impact factor: 26.132

8.  Giardia/Cryptosporidium QUIK CHEK Assay Is More Specific Than Quantitative Polymerase Chain Reaction for Rapid Point-of-care Diagnosis of Cryptosporidiosis in Infants in Bangladesh.

Authors:  Mamun Kabir; Emtiaz Ahmed; Biplob Hossain; Masud Alam; Shahnawaz Ahmed; Mami Taniuchi; Carol A Gilchrist; Eric R Houpt; A S G Faruque; William A Petri; Rashidul Haque
Journal:  Clin Infect Dis       Date:  2018-11-28       Impact factor: 9.079

9.  Human intestinal parasites.

Authors:  Rashidul Haque
Journal:  J Health Popul Nutr       Date:  2007-12       Impact factor: 2.000

10.  Experiences from occupational exposure limits set on aerosols containing allergenic proteins.

Authors:  Gunnar D Nielsen; Søren T Larsen; Jitka S Hansen; Lars K Poulsen
Journal:  Ann Occup Hyg       Date:  2012-07-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.